ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities

New Area Decontamination Technology Broadens ASP's Portfolio of Infection Prevention Solutions by Providing Patients with Assurance that Their Hospital Environment is Disinfected

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets

Exciting 3D Printing Advances from Objet Attract EuroMold 2009 Attendees

Live Customer Presentations and Latest Systems on Display at HALL 11, STAND C-92

BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries

MINNEAPOLIS, November 23 - BridgePoint Medical announced today that it received European CE Mark
(Conformite Europeene) for its coronary and peripheral Chronic Total
Occlusion (CTO) Crossing System comprised of the CrossBoss(TM) CTO Crossing
Catheter and the Stingray(R) CTO Re-Entry System. The BridgePoint System is a
series of interventional catheters that are designed to navigate highly
diseased arteries in preparation for blood flow restoration via angioplasty
and stenting.

Visage Imaging Signs University of Chicago

Visage CS Enterprise Wide Advanced Visualization Solutions

ANDOVER, Massachusetts, November 19 - Visage Imaging(R), Inc., a wholly owned subsidiary of Pro Medicus Ltd.
(ASX: PME), announced today it has installed their Visage CS thin client
enterprise solution with The University of Chicago to meet an evolving demand
for powerful workflow improvement. The Visage CS's architecture has been
designed to smoothly integrate with their existing workflow and allow for a
greater level of performance and productivity throughout the enterprise.

New H1N1 Flu Test Available Now - On Display At MEDICA 2009

2009 H1N1 Flu Test from Quest Diagnostics Now CE Marked For International Distribution under the Simplexa(TM) brand name

Varian Medical Systems to Showcase the Latest X-Ray Image Detectors and X-Ray Tubes at the MEDICA 2009 International Trade Fair

SALT LAKE CITY, November 18 - Booth - A78/Hall 10 - Varian Medical Systems, Inc. (NYSE: VAR), a premier
supplier of X-ray tubes and flat panel digital image detectors, will exhibit
its PaxScan digital image detectors and its line of X-ray tubes for
fluoroscopy, angiography, cardiology and cone-beam CT imaging at the MEDICA
2009 International Trade Fair in Dusseldorf, Germany from November 18-21,
2009.

Health Robotics Announces Worldwide Launch of the "i.v. Room of the Future" Concept at Las Vegas' ASHP

BOZEN, Italy, November 18 - Health Robotics today announced the worldwide presentation and launch of
its revolutionary vision for "The i.v. Room of the Future" at the American
Society of Health-System Pharmacists' Mid-Year Meeting December 6-10 in Las
Vegas, along with an initial consortium of development partners that
currently includes Biomedical Technology Consulting and MEDarchiver.

Sanofi-aventis Launches Major New Registry Including Over 10,000 Patients Worldwide With Atrial Fibrillation

The RealiseAF Registry Will Help to Better Define and Understand the Cardiovascular Risk Profile of AF Patients and Characterize Their Cardiovascular Outcomes

Bluestar Silicones to Make its Debut at MEDICA 2009 in Düsseldorf to Showcase the Silbione(R) Difference

LYON, France, November 12 - Bluestar Silicones will make its debut at MEDICA 2009 in Düsseldorf to
showcase its innovative and skin-friendly Silbione(R) range of silicones
products.

Health Robotics Reaches 100% Asia-Pacific Coverage Through its New Exclusive Distribution Contract With BioRobotics in Korea

BOZEN, SUD-TYROL, Italy, November 12 - Health Robotics today announced that Innomed/BioRobotics, on the heels of
its prior market success with Oncology Surgery robots, has exclusively
selected Health Robotics' CytoCare(TM) Robot to reach its objective to become
the gold standard for Oncology Robotics IV Admixtures in the Republic of
Korea and synergistically provide an end-to-end Cancer Robotics solution.

Service Outsourcing Opportunities in Medical Device Market worth US$26.77 Billion by 2014

WILMINGTON, Delaware, November 12 - According to a new market research report, 'Service
Outsourcing Opportunities in Medical Device Market (2009-2014)', published by
MarketsandMarkets (www.marketsandmarkets.com), the global services
outsourcing market in medical devices is expected to be worth $26,770 million
by 2014, growing at a CAGR of 13.9% from 2009 to 2014.

Barely a Bruise on New World Heavyweight Boxing Champion

STUTTGART, Germany, November 11 - New WBA heavyweight champion David 'The Hayemaker' Haye appears barely
bruised just days after a gruelling fight where he defeated 7-foot-tall
'Beast from the East' Nikolai Valuev, thanks to a new healing technology
which helps him recuperate from injuries and which has been hailed by some of
the world's top plastic surgeons as the ideal solution for their facelift and
breast augmentation patients. Hilotherapy (www.hilotherapy.com) is a
patented treatment which drastically reduces post-trauma swelling and pain
-in many instances eliminating bruising altogether- by circulating cool water
through adaptable cuffs that comfortably fit most parts of the body and face,
avoiding the risk of nerve and tissue damage by using controlled
temperatures.

Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States

PHILADELPHIA -

- Partnership With Elsevier Continues Tradition of Excellence in Serving Healthcare Needs of Patients in California, Idaho, Indiana, Iowa, Maryland, Michigan and Ohio

Central and Eastern European Healthcare Markets Hold Strong Potential for Growth Despite the Economic Slowdown, Says Frost & Sullivan

LONDON -

Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market. Both the pharmaceutical as well as medical devices segments have not developed to their full potential, with healthcare expenditures expected to rise further. The increasing importance of this market is attracting multinational corporations (MNCs) for developing proprietary or acquiring local production sites. Merger with or an acquisition of a local market participant is considered as the most efficient way to access the local market and to further expand into the CEE markets.

William Cork Joins Fenwal as Chief Technology Officer

LAKE ZURICH, Illinois, November 10 - Fenwal Inc., a global medical technology company focused on improving
blood collection, separation, safety and availability, announced today
William H. Cork has joined the company as senior vice president and chief
technology officer. Mr. Cork, 50, will lead Fenwal's research and
development, regulatory and clinical affairs teams, reporting to Ron K.
Labrum, Fenwal's president and chief executive officer.

Novel Laser Coding Technology for Pharmaceutical Glass Containers

ST GALLEN, Switzerland -

- Glass Syringes can now be Individually Coded / Safe Process Free of Micro-Cracks / Reliable Track & Trace

Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings

RICHMOND, Virginia -

Filtrona Porous Technologies, manufacturer of custom fluid handling fiber and foam components for the medical device and healthcare industry, and a division of UK-based Filtrona plc (Pink Sheets: FLRAF), has recently developed a unique foam-fiber hybrid component for select medical and personal care markets, specifically wound care. Referred to as MediSponge(R) RBR, the patent-pending foam-fiber composite consists of a soft, highly absorbent foam with hydrophilic properties structurally enhanced by the addition of a fiber matrix. The development represents yet another innovation by Filtrona Porous Technologies in the area of specialty healthcare industry products.

Helix BioPharma Corp. Announces Fiscal 2009 Results

AURORA, Ontario -

Helix BioPharma Corp. (TSX, FSE: HBP / OTCQX: HXBPF) today announced financial results for the year ended July 31, 2009.

U.S. FDA Officials to Speak at RAPS Medical Device Workshop in Brussels

ROCKVILLE, Maryland -

The Regulatory Affairs Professionals Society (RAPS), the leading international membership organization for regulatory professionals in the healthcare product sector, will bring together medical device industry experts and regulators from the U.S. Food and Drug Administration (FDA) in Brussels for a workshop on U.S. device submission and compliance. The two-day event, Medical Device Submission and Compliance Strategies for the U.S. Market, will take place 9-10 November at the Sheraton Brussels Hotel.

CCBR-SYNARC Expands Electronic Data Capture Capabilities

SAN FRANCISCO -

CCBR-SYNARC, the world’s leading provider of medical image analysis, biochemical marker, and clinical research center services to the pharmaceutical and biotechnology industries, announced the expansion of its Electronic Data Capture (”EDC”) capabilities for use in imaging clinical trials.

AMT Starts Development LPLChip(TM) With Progenika

AMSTERDAM - Amsterdam Molecular Therapeutics (AMT) and Progenika Biopharma announced today that the companies have entered into a development and commercialization agreement for LPLchip(TM), a diagnostic tool to rapidly diagnose patients with complete and partial lipoprotein lipase deficiency (LPLD). AMT has developed Glybera(R) as a gene therapy for patients with this disease.

Whitepaper From Mirial Explains how Visual Communication Technology can Improve Healthcare Services

MILAN - Mirial has just released a new whitepaper, An Interactive Visual Communication Architecture Proposal For Telehealth, which explains in details the benefits of Telehealth and how to leverage visual communication technology for implementing interactive Telehealth services.

Roche Introduces New cobas p 630 Instrument and AMPLILINK 3.3 Series Software With CE Mark

PLEASANTON, California -

- New pre-analytical solution that integrates automated primary tube handling

Cell Biosciences Completes Acquisition of Alpha Innotech

SANTA CLARA, California -

Cell Biosciences, Inc. today announced that it has completed its acquisition of Alpha Innotech Corp. (OTC Bulletin Board: APNO). The stockholders of Alpha Innotech have approved the transaction, and all regulatory and other conditions have been satisfied. Pursuant to the merger agreement announced on September 8, 2009, former Alpha Innotech stockholders will receive US$1.50 per share, or approximately US$17.9 million in cash.

eBioscience Acquires Bender MedSystems; Business Combination Adds Cutting-Edge Product Lines and Expands International Operations

SAN DIEGO and VIENNA -

eBioscience Corporation today announced that it has acquired privately held immunoassay technology pioneer Bender MedSystems GmbH in an all cash transaction. The acquisition will provide eBioscience with over 1,000 high profile immunology and oncology products including the Instant ELISA(R) and FlowCytomix(TM) brands that target the life sciences and diagnostics markets.

Simbionix Introduces the Next Generation in Bronchoscopy Training

CLEVELAND, Ohio - Simbionix, the world’s leading developer of medical simulation systems, introduces it’s new advanced simulator, the GI-BRONCH Mentor, a comprehensive solution for virtual reality training of GI Endoscopy and Flexible Bronchoscopy.

Novo Nordisk Wins Design Award for NovoTwist(TM) Needle

COPENHAGEN - Novo Nordisk has been awarded a Good Design Award(TM)(1) for NovoTwist(TM), the new needle designed for use with the insulin delivery device FlexPen(R). The needle, which has a simple ‘just twist’ attachment and detachment, makes injection easier for people with diabetes.

Novel Cardio-Pulmonary Support Device LIFEBRIDGE(R) From Germany Gains FDA Clearance

AMPFING, Germany -

- LIFEBRIDGE Medizintechnik gets Go-ahead on the US Market

German based LIFEBRIDGE AG has received clearance from the U.S. Food and Drug Administration (FDA) for a compact, lightweight, mobile heart-lung machine, a first for any manufacturer worldwide.

Nucleus Replacement - Next Big Opportunity in the Spinal Surgery Devices Market

Europe Spinal Surgery Devices Market: Increasing Procedures to Drive Growth report ( http://www.bharatbook.com/Market-Research-Reports/Europe-Spinal-Surgery-Devices-Market-Increasing-Procedures-to-Drive-Growth.html ) is an essential source of data and analysis on Europe spinal surgery devices market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on two market categories – spinal fusion and spinal non-fusion. The report identifies the key trends shaping and driving the dynamism in Europe spinal surgery devices market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within Europe spinal surgery devices market.

Essilor - 2009 Third Quarter Report

CHARENTON-LE-PONT, France -

- Nine-Month Revenue up 8.4%

- Positive Like-for-Like Growth in the Third Quarter

Arab Health 2010: Ansell Showcases Latest Innovations in Hand Protection Solutions Dedicated to Healthcare Professionals

BRUSSELS -

- Comprehensive Gammex(R) Surgical Range and a Wide Selection of Examination Gloves Offer Optimal Protection and Prevent Infections and Allergies

MAQUET Cardiovascular Receives CE Approval for MEGA(TM), the World’s First 8Fr. 50cc Intra-Aortic Balloon Catheter

FAIRFIELD, New Jersey -

- Small Shaft Size on MEGA Benefits More Patients

MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, announced that it received European CE Mark for the company’s MEGA(TM) 8Fr. 50cc intra-aortic balloon (IAB) catheter. As the world’s first 50cc IAB with a true 8Fr. shaft, the MEGA has a smaller insertion point than traditional 50cc IABs and offers additional blood volume displacement for intra-aortic balloon counterpulsation. MEGA, compared to 40cc IABs, delivers 25% more blood volume displacement and provides improved unloading and augmentation.* The MEGA will be available for distribution in CE countries October, 2009.

New Data Demonstrate for the First Time STERRAD(R) NX(TM) System Technology Effective in Prion Inactivation (Only for Use Outside the U.S.)

PARIS -

- Multiple Tests Show Gaseous Hydrogen Peroxide STERRAD(R) Sterilization System Technology Efficiently Inactivates Protein-based Infectious Agents Linked to Fatal Brain Diseases

New IOF Report Supports Understanding of FRAX(R)

NYON, Switzerland - The International Osteoporosis Foundation (IOF) will issue a new 16-page report on FRAX(R) to mark World Osteoporosis Day. The report is available at www.iofbonehealth.org.